Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences
MJH Life Sciences

SUBSCRIBE: Print / eNewsletter

ARS 2016

American Radium Society Scientific Papers and Posters 2016

A Century of Caring

Proceedings of the 100th Anniversary Annual Meeting of the

  • READ >>

(P045) Esophagus Dose Tolerance for Stereotactic Body Radiation Therapy (SBRT)

Four articles reported five deaths due to esophageal toxicity; so, our dose escalation began cautiously, and as a result, no grade ≥ 3 esophageal toxicity occurred in our series.

  • READ >>
  • Add new comment

(P044) Comparison of Toxicity-Related Breaks in Treatment Utilizing Intensity-Modulated Radiation Therapy (IMRT) vs Three-Dimensional (3D) Conformal Techniques in the Treatment of Anal Cancer

In our small cohorts, no significant difference was seen in toxicity-related treatment breaks between IMRT and three-dimensional conformal RT.

  • READ >>
  • Add new comment

(P043) Postoperative Bolus Electron Conformal Radiation Therapy for Soft Tissue Tumors: Initial Clinical Experience

Bolus electron conformal radiation therapy for the postoperative treatment of superficial soft tissue tumors resulted in favorable tumor control outcomes and limited radiation-related toxicity.

  • READ >>
  • Add new comment

(P042) Development of an Integrated Microfluidic Platform for Automated Proteomic Assay Predictive of Radiation Therapy Outcomes

April 15, 2016

Such a platform technology will allow a point-of-care assay to be set up for the prediction of normal tissue toxicity after RT and ultimately for the monitoring of any intracellular protein assay diagnostic method.

  • READ >>
  • Add new comment

(P041) Small Bowel Dose Tolerance in Stereotactic Body Radiation Therapy (SBRT) With Tumor Growth Inhibitors

April 15, 2016

Tumor growth factor inhibitors may cause more toxicity with SBRT than would otherwise be anticipated, although the absence of complications in our patients allows cautious optimism.

  • READ >>
  • Add new comment

(P039) Dose-Dependent Change in T2 Relaxation Time Constant in Sarcoma and Normal Tissue

April 15, 2016

Our results demonstrate that there is a measurable T2 relaxation time constant change in retroperitoneal sarcoma after 28 Gy.

  • READ >>
  • Add new comment

(P038) An MRI-Based Online Adaptive Replanning Tool

April 15, 2016

The online tool is developed to perform three different plan adaptation strategies—simple, moderate, and complex—based on the degree of the interfractional variations.

  • READ >>
  • Add new comment

(P037) Treatment of Prognostically Favorable Peripheral Nerve Sheath Tumors: A Single-Institution Experience

April 15, 2016

Both surgery and radiation are very well tolerated treatment regimens with limited and manageable toxicity in favorable patients. Outcomes in patients with peripheral nerve sheath tumors

  • READ >>
  • Add new comment

(P036) Causes of Mortality Among Cancer Patients

April 15, 2016

Cancer patients with the highest risk of index and nonindex cancer death and medical comorbidity death are identified; certain patient groups may be targeted with interventions.

  • READ >>
  • Add new comment
Browse more articles

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Breast Cancer
  • Acute Myeloid Leukemia
  • HER2-Positive Breast Cancer
  • Videos Breast Cancer
  • Follicular Lymphoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

ONCOLOGY Vol 33 No 11
Nov 21, 2019 Vol 33 No 11
Subscribe
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".